Overview Fundamentals API Earnings EOD API Sample Code Pricing

Telix Pharmaceuticals Limited American Depositary Shares (TLX NASDAQ) stock market data APIs

$15.68 -0.08(-0.5%) as of December 13, 2024
Price chart is built with Anychart

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; and TLX250 for the treatment of clear cell renal cell carcinoma. The company also develops TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning; TLX300 for the treatment of soft tissue sarcoma; and TLX592, a prostate cancer therapy candidate for targeted alpha therapy. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.

Telix Pharmaceuticals Limited American Depositary Shares Financial Data Overview

15.76
15.68
-
16.5
15.68
0-19.99
5 222 M
156
335 M
646 M
2.384
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TLX',
Type: 'Common Stock',
Name: 'Telix Pharmaceuticals Limited American Depositary Shares',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01N69K900',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2024-11-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Telix Pharmaceuticals Limited American Depositary Shares Fundamental Data is available in our Financial Data APIs

  • Net Revenue 646 M
  • EBITDA 73 142 K
  • Earnings Per Share 0.1
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Telix Pharmaceuticals Limited American Depositary Shares Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Telix Pharmaceuticals Limited American Depositary Shares End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com